Acknowledgment

This work was supported by the National Natural Science Foundation (NSFC81502677, NSFC81602699, NSFC81123003), the National Key Research and Development Program of China (2016YFA0201402), and the Key Technologies R & D program of Sichuan Province (2015FZ0040).

Interest statement

The author(s) declare that they have no conflict of interest.

References

[1] Aartsma-Rus A., Kaman W.E., Weij R., den Dunnen J.T., van Ommen G.J.B., van Deutekom J.C.T.. Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons. Mol Ther, 2006, 14: 401-407 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons&author=Aartsma-Rus A.&author=Kaman W.E.&author=Weij R.&author=den Dunnen J.T.&author=van Ommen G.J.B.&author=van Deutekom J.C.T.&publication_year=2006&journal=Mol Ther&volume=14&pages=401-407

[2] Aartsma-Rus A., Fokkema I., Verschuuren J., Ginjaar I., van Deutekom J., van Ommen G.J., den Dunnen J.T.. Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Hum Mutat, 2009, 30: 293-299 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations&author=Aartsma-Rus A.&author=Fokkema I.&author=Verschuuren J.&author=Ginjaar I.&author=van Deutekom J.&author=van Ommen G.J.&author=den Dunnen J.T.&publication_year=2009&journal=Hum Mutat&volume=30&pages=293-299

[3] Aoki Y., Yokota T., Nagata T., Nakamura A., Tanihata J., Saito T., Duguez S.M.R., Nagaraju K., Hoffman E.P., Partridge T., Takeda S.. Bodywide skipping of exons 45–55 in dystrophic mdx52 mice by systemic antisense delivery. Proc Natl Acad Sci USA, 2012, 109: 13763-13768 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Bodywide skipping of exons 45–55 in dystrophic mdx52 mice by systemic antisense delivery&author=Aoki Y.&author=Yokota T.&author=Nagata T.&author=Nakamura A.&author=Tanihata J.&author=Saito T.&author=Duguez S.M.R.&author=Nagaraju K.&author=Hoffman E.P.&author=Partridge T.&author=Takeda S.&publication_year=2012&journal=Proc Natl Acad Sci USA&volume=109&pages=13763-13768

[4] Asokan A., Schaffer D.V., Jude Samulski R.. The AAV vector toolkit: poised at the clinical crossroads. Mol Ther, 2012, 20: 699-708 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=The AAV vector toolkit: poised at the clinical crossroads&author=Asokan A.&author=Schaffer D.V.&author=Jude Samulski R.&publication_year=2012&journal=Mol Ther&volume=20&pages=699-708

[5] Avior Y., Sagi I., Benvenisty N.. Pluripotent stem cells in disease modelling and drug discovery. Nat Rev Mol Cell Biol, 2016, 17: 170-182 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Pluripotent stem cells in disease modelling and drug discovery&author=Avior Y.&author=Sagi I.&author=Benvenisty N.&publication_year=2016&journal=Nat Rev Mol Cell Biol&volume=17&pages=170-182

[6] Azuma H., Paulk N., Ranade A., Dorrell C., Al-Dhalimy M., Ellis E., Strom S., Kay M.A., Finegold M., Grompe M.. Robust expansion of human hepatocytes in Fah^?/?/Rag2^?/?/Il2rg^?/? mice. Nat Biotechnol, 2007, 25: 903-910 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Robust expansion of human hepatocytes in Fah^?/?/Rag2^?/?/Il2rg^?/? mice&author=Azuma H.&author=Paulk N.&author=Ranade A.&author=Dorrell C.&author=Al-Dhalimy M.&author=Ellis E.&author=Strom S.&author=Kay M.A.&author=Finegold M.&author=Grompe M.&publication_year=2007&journal=Nat Biotechnol&volume=25&pages=903-910

[7] Bamshad M.J., Ng S.B., Bigham A.W., Tabor H.K., Emond M.J., Nickerson D.A., Shendure J.. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet, 2011, 12: 745-755 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Exome sequencing as a tool for Mendelian disease gene discovery&author=Bamshad M.J.&author=Ng S.B.&author=Bigham A.W.&author=Tabor H.K.&author=Emond M.J.&author=Nickerson D.A.&author=Shendure J.&publication_year=2011&journal=Nat Rev Genet&volume=12&pages=745-755

[8] Bassuk A.G., Zheng A., Li Y., Tsang S.H., Mahajan V.B.. Precision medicine: genetic repair of retinitis pigmentosa in patient-derived stem cells. Sci Rep, 2016, 6: 19969 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Precision medicine: genetic repair of retinitis pigmentosa in patient-derived stem cells&author=Bassuk A.G.&author=Zheng A.&author=Li Y.&author=Tsang S.H.&author=Mahajan V.B.&publication_year=2016&journal=Sci Rep&volume=6&pages=19969

[9] Beckmann J.S., Estivill X., Antonarakis S.E.. Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat Rev Genet, 2007, 8: 639-646 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability&author=Beckmann J.S.&author=Estivill X.&author=Antonarakis S.E.&publication_year=2007&journal=Nat Rev Genet&volume=8&pages=639-646

[10] Blasco R.B., Karaca E., Ambrogio C., Cheong T.C., Karayol E., Minero V.G., Voena C., Chiarle R.. Simple and rapid in vivo generation of chromosomal rearrangements using CRISPR/Cas9 technology. Cell Rep, 2014, 9: 1219-1227 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Simple and rapid in vivo generation of chromosomal rearrangements using CRISPR/Cas9 technology&author=Blasco R.B.&author=Karaca E.&author=Ambrogio C.&author=Cheong T.C.&author=Karayol E.&author=Minero V.G.&author=Voena C.&author=Chiarle R.&publication_year=2014&journal=Cell Rep&volume=9&pages=1219-1227

[11] Bondeson M.L., Dahl N., Malmgren H., Kleijer W.J., T?nnesen T., Carlberg B.M., Pettersson U.. Inversion of the IDS gene resulting from recombination with IDS-related sequences in a common cause of the Hunter syndrome. Hum Mol Genet, 1995, 4: 615-621 CrossRef Google Scholar http://scholar.google.com/scholar_lookup?title=Inversion of the IDS gene resulting from recombination with IDS-related sequences in a common cause of the Hunter syndrome&author=Bondeson M.L.&author=Dahl N.&author=Malmgren H.&author=Kleijer W.J.&author=T?nnesen T.&author=Carlberg B.M.&author=Pettersson U.&publication_year=1995&journal=Hum Mol Genet&volume=4&pages=615-621

[12] Carbery I.D., Ji D., Harrington A., Brown V., Weinstein E.J., Liaw L., Cui X.. Targeted genome modification in mice using zinc-finger nucleases. Genets, 2010, 186: 451-459 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Targeted genome modification in mice using zinc-finger nucleases&author=Carbery I.D.&author=Ji D.&author=Harrington A.&author=Brown V.&author=Weinstein E.J.&author=Liaw L.&author=Cui X.&publication_year=2010&journal=Genets&volume=186&pages=451-459

[13] Chang C.W., Lai Y.S., Westin E., Khodadadi-Jamayran A., Pawlik K.M., Lamb Jr. L.S., Goldman F.D., Townes T.M.. Modeling human severe combined immunodeficiency and correction by CRISPR/Cas9-enhanced gene targeting. Cell Rep, 2015, 12: 1668-1677 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Modeling human severe combined immunodeficiency and correction by CRISPR/Cas9-enhanced gene targeting&author=Chang C.W.&author=Lai Y.S.&author=Westin E.&author=Khodadadi-Jamayran A.&author=Pawlik K.M.&author=Lamb Jr. L.S.&author=Goldman F.D.&author=Townes T.M.&publication_year=2015&journal=Cell Rep&volume=12&pages=1668-1677

[14] Chang N., Sun C., Gao L., Zhu D., Xu X., Zhu X., Xiong J.W., Xi J.J.. Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res, 2013, 23: 465-472 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos&author=Chang N.&author=Sun C.&author=Gao L.&author=Zhu D.&author=Xu X.&author=Zhu X.&author=Xiong J.W.&author=Xi J.J.&publication_year=2013&journal=Cell Res&volume=23&pages=465-472

[15] Chen F., Pruett-Miller S.M., Huang Y., Gjoka M., Duda K., Taunton J., Collingwood T.N., Frodin M., Davis G.D.. High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Meth, 2011, 8: 753-755 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases&author=Chen F.&author=Pruett-Miller S.M.&author=Huang Y.&author=Gjoka M.&author=Duda K.&author=Taunton J.&author=Collingwood T.N.&author=Frodin M.&author=Davis G.D.&publication_year=2011&journal=Nat Meth&volume=8&pages=753-755

[16] Cheng S.H., Gregory R.J., Marshall J., Paul S., Souza D.W., White G.A., O’Riordan C.R., Smith A.E.. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell, 1990, 63: 827-834 CrossRef Google Scholar http://scholar.google.com/scholar_lookup?title=Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis&author=Cheng S.H.&author=Gregory R.J.&author=Marshall J.&author=Paul S.&author=Souza D.W.&author=White G.A.&author=O’Riordan C.R.&author=Smith A.E.&publication_year=1990&journal=Cell&volume=63&pages=827-834

[17] Chen Z.G., Zhang Y.A.. Cell therapy for macular degeneration—first phase I/II pluripotent stem cell-based clinical trial shows promise. Sci China Life Sci, 2015, 58: 119-120 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Cell therapy for macular degeneration—first phase I/II pluripotent stem cell-based clinical trial shows promise&author=Chen Z.G.&author=Zhang Y.A.&publication_year=2015&journal=Sci China Life Sci&volume=58&pages=119-120

[18] Cho S.W., Kim S., Kim J.M., Kim J.S.. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol, 2013, 31: 230-232 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease&author=Cho S.W.&author=Kim S.&author=Kim J.M.&author=Kim J.S.&publication_year=2013&journal=Nat Biotechnol&volume=31&pages=230-232

[19] Choi P.S., Meyerson M.. Targeted genomic rearrangements using CRISPR/Cas technology. Nat Commun, 2014, 5: 3728 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Targeted genomic rearrangements using CRISPR/Cas technology&author=Choi P.S.&author=Meyerson M.&publication_year=2014&journal=Nat Commun&volume=5&pages=3728

[20] Cong L., Ran F.A., Cox D., Lin S., Barretto R., Habib N., Hsu P.D., Wu X., Jiang W., Marraffini L.A., Zhang F.. Multiplex genome engineering using CRISPR/Cas systems. Science, 2013, 339: 819-823 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Multiplex genome engineering using CRISPR/Cas systems&author=Cong L.&author=Ran F.A.&author=Cox D.&author=Lin S.&author=Barretto R.&author=Habib N.&author=Hsu P.D.&author=Wu X.&author=Jiang W.&author=Marraffini L.A.&author=Zhang F.&publication_year=2013&journal=Science&volume=339&pages=819-823

[21] Davidoff A.M., Gray J.T., Ng C.Y.C., Zhang Y., Zhou J., Spence Y., Bakar Y., Nathwani A.C.. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models. Mol Ther, 2005, 11: 875-888 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models&author=Davidoff A.M.&author=Gray J.T.&author=Ng C.Y.C.&author=Zhang Y.&author=Zhou J.&author=Spence Y.&author=Bakar Y.&author=Nathwani A.C.&publication_year=2005&journal=Mol Ther&volume=11&pages=875-888

[22] Dickinson D.J., Ward J.D., Reiner D.J., Goldstein B.. Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination. Nat Meth, 2013, 10: 1028-1034 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination&author=Dickinson D.J.&author=Ward J.D.&author=Reiner D.J.&author=Goldstein B.&publication_year=2013&journal=Nat Meth&volume=10&pages=1028-1034

[23] Ding Q., Strong A., Patel K.M., Ng S.L., Gosis B.S., Regan S.N., Cowan C.A., Rader D.J., Musunuru K.. Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing. Circul Res, 2014, 115: 488-492 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing&author=Ding Q.&author=Strong A.&author=Patel K.M.&author=Ng S.L.&author=Gosis B.S.&author=Regan S.N.&author=Cowan C.A.&author=Rader D.J.&author=Musunuru K.&publication_year=2014&journal=Circul Res&volume=115&pages=488-492

[24] Filareto A., Parker S., Darabi R., Borges L., Iacovino M., Schaaf T., Mayerhofer T., Chamberlain J.S., Ervasti J.M., McIvor R.S., Kyba M., Perlingeiro R.C.R.. An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells. Nat Commun, 2013, 4: 1549 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells&author=Filareto A.&author=Parker S.&author=Darabi R.&author=Borges L.&author=Iacovino M.&author=Schaaf T.&author=Mayerhofer T.&author=Chamberlain J.S.&author=Ervasti J.M.&author=McIvor R.S.&author=Kyba M.&author=Perlingeiro R.C.R.&publication_year=2013&journal=Nat Commun&volume=4&pages=1549

[25] Flynn R., Grundmann A., Renz P., H?nseler W., James W.S., Cowley S.A., Moore M.D.. CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells. Exp Hematol, 2015, 43: 838-848.e3 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells&author=Flynn R.&author=Grundmann A.&author=Renz P.&author=H?nseler W.&author=James W.S.&author=Cowley S.A.&author=Moore M.D.&publication_year=2015&journal=Exp Hematol&volume=43&pages=838-848.e3

[26] Frazer K.A., Murray S.S., Schork N.J., Topol E.J.. Human genetic variation and its contribution to complex traits. Nat Rev Genet, 2009, 10: 241-251 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Human genetic variation and its contribution to complex traits&author=Frazer K.A.&author=Murray S.S.&author=Schork N.J.&author=Topol E.J.&publication_year=2009&journal=Nat Rev Genet&volume=10&pages=241-251

[27] Friedland A.E., Tzur Y.B., Esvelt K.M., Colaiácovo M.P., Church G.M., Calarco J.A.. Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Meth, 2013, 10: 741-743 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Heritable genome editing in C. elegans via a CRISPR-Cas9 system&author=Friedland A.E.&author=Tzur Y.B.&author=Esvelt K.M.&author=Colaiácovo M.P.&author=Church G.M.&author=Calarco J.A.&publication_year=2013&journal=Nat Meth&volume=10&pages=741-743

[28] Gao X.. Model animals and their applications. Sci China Life Sci, 2015, 58: 319-320 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Model animals and their applications&author=Gao X.&publication_year=2015&journal=Sci China Life Sci&volume=58&pages=319-320

[29] Gilissen C., Hoischen A., Brunner H.G., Veltman J.A.. Unlocking Mendelian disease using exome sequencing. Genome Biol, 2011, 12: 228 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Unlocking Mendelian disease using exome sequencing&author=Gilissen C.&author=Hoischen A.&author=Brunner H.G.&author=Veltman J.A.&publication_year=2011&journal=Genome Biol&volume=12&pages=228

[30] Graw J., Brackmann H.H., Oldenburg J., Schneppenheim R., Spannagl M., Schwaab R.. Haemophilia A: from mutation analysis to new therapies. Nat Rev Genet, 2005, 6: 488-501 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Haemophilia A: from mutation analysis to new therapies&author=Graw J.&author=Brackmann H.H.&author=Oldenburg J.&author=Schneppenheim R.&author=Spannagl M.&author=Schwaab R.&publication_year=2005&journal=Nat Rev Genet&volume=6&pages=488-501

[31] Hanna J., Wernig M., Markoulaki S., Sun C.W., Meissner A., Cassady J.P., Beard C., Brambrink T., Wu L.C., Townes T.M., Jaenisch R.. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 2007, 318: 1920-1923 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin&author=Hanna J.&author=Wernig M.&author=Markoulaki S.&author=Sun C.W.&author=Meissner A.&author=Cassady J.P.&author=Beard C.&author=Brambrink T.&author=Wu L.C.&author=Townes T.M.&author=Jaenisch R.&publication_year=2007&journal=Science&volume=318&pages=1920-1923

[32] Hoffman E.P., Brown Jr. R.H., Kunkel L.M.. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 1987, 51: 919-928 CrossRef Google Scholar http://scholar.google.com/scholar_lookup?title=Dystrophin: the protein product of the Duchenne muscular dystrophy locus&author=Hoffman E.P.&author=Brown Jr. R.H.&author=Kunkel L.M.&publication_year=1987&journal=Cell&volume=51&pages=919-928

[33] Huang X., Wang Y., Yan W., Smith C., Ye Z., Wang J., Gao Y., Mendelsohn L., Cheng L.. Production of gene-corrected adult beta globin protein in human erythrocytes differentiated from patient iPSCs after genome editing of the sickle point mutation. Stem Cells, 2015, 33: 1470-1479 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Production of gene-corrected adult beta globin protein in human erythrocytes differentiated from patient iPSCs after genome editing of the sickle point mutation&author=Huang X.&author=Wang Y.&author=Yan W.&author=Smith C.&author=Ye Z.&author=Wang J.&author=Gao Y.&author=Mendelsohn L.&author=Cheng L.&publication_year=2015&journal=Stem Cells&volume=33&pages=1470-1479

[34] Huertas P.. DNA resection in eukaryotes: deciding how to fix the break. Nat Struct Mol Biol, 2010, 17: 11-16 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=DNA resection in eukaryotes: deciding how to fix the break&author=Huertas P.&publication_year=2010&journal=Nat Struct Mol Biol&volume=17&pages=11-16

[35] Hwang W.Y., Fu Y., Reyon D., Maeder M.L., Tsai S.Q., Sander J.D., Peterson R.T., Yeh J.R.J., Joung J.K.. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol, 2013, 31: 227-229 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Efficient genome editing in zebrafish using a CRISPR-Cas system&author=Hwang W.Y.&author=Fu Y.&author=Reyon D.&author=Maeder M.L.&author=Tsai S.Q.&author=Sander J.D.&author=Peterson R.T.&author=Yeh J.R.J.&author=Joung J.K.&publication_year=2013&journal=Nat Biotechnol&volume=31&pages=227-229

[36] Inagaki K., Fuess S., Storm T.A., Gibson G.A., Mctiernan C.F., Kay M.A., Nakai H.. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol Ther, 2006, 14: 45-53 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8&author=Inagaki K.&author=Fuess S.&author=Storm T.A.&author=Gibson G.A.&author=Mctiernan C.F.&author=Kay M.A.&author=Nakai H.&publication_year=2006&journal=Mol Ther&volume=14&pages=45-53

[37] Jao L.E., Wente S.R., Chen W.. Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc Natl Acad Sci USA, 2013, 110: 13904-13909 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system&author=Jao L.E.&author=Wente S.R.&author=Chen W.&publication_year=2013&journal=Proc Natl Acad Sci USA&volume=110&pages=13904-13909

[38] Jinek M., East A., Cheng A., Lin S., Ma E., Doudna J.. RNA-programmed genome editing in human cells. eLife, 2013, 2: e00471 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=RNA-programmed genome editing in human cells&author=Jinek M.&author=East A.&author=Cheng A.&author=Lin S.&author=Ma E.&author=Doudna J.&publication_year=2013&journal=eLife&volume=2&pages=e00471

[39] Kay M.A., Manno C.S., Ragni M.V., Larson P.J., Couto L.B., McClelland A., Glader B., Chew A.J., Tai S.J., Herzog R.W., Arruda V., Johnson F., Scallan C., Skarsgard E., Flake A.W., High K.A.. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet, 2000, 24: 257-261 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector&author=Kay M.A.&author=Manno C.S.&author=Ragni M.V.&author=Larson P.J.&author=Couto L.B.&author=McClelland A.&author=Glader B.&author=Chew A.J.&author=Tai S.J.&author=Herzog R.W.&author=Arruda V.&author=Johnson F.&author=Scallan C.&author=Skarsgard E.&author=Flake A.W.&author=High K.A.&publication_year=2000&journal=Nat Genet&volume=24&pages=257-261

[40] Kimbrel E.A., Lanza R.. Current status of pluripotent stem cells: moving the first therapies to the clinic. Nat Rev Drug Discov, 2015, 14: 681-692 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Current status of pluripotent stem cells: moving the first therapies to the clinic&author=Kimbrel E.A.&author=Lanza R.&publication_year=2015&journal=Nat Rev Drug Discov&volume=14&pages=681-692

[41] Li H.L., Fujimoto N., Sasakawa N., Shirai S., Ohkame T., Sakuma T., Tanaka M., Amano N., Watanabe A., Sakurai H., Yamamoto T., Yamanaka S., Hotta A.. Precise correction of the dystrophin gene in Duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9. Stem Cell Rep, 2015, 4: 143-154 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Precise correction of the dystrophin gene in Duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9&author=Li H.L.&author=Fujimoto N.&author=Sasakawa N.&author=Shirai S.&author=Ohkame T.&author=Sakuma T.&author=Tanaka M.&author=Amano N.&author=Watanabe A.&author=Sakurai H.&author=Yamamoto T.&author=Yamanaka S.&author=Hotta A.&publication_year=2015&journal=Stem Cell Rep&volume=4&pages=143-154

[42] Li W., Teng F., Li T., Zhou Q.. Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat Biotechnol, 2013, 31: 684-686 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems&author=Li W.&author=Teng F.&author=Li T.&author=Zhou Q.&publication_year=2013&journal=Nat Biotechnol&volume=31&pages=684-686

[43] Lisowski L., Dane A.P., Chu K., Zhang Y., Cunningham S.C., Wilson E.M., Nygaard S., Grompe M., Alexander I.E., Kay M.A.. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model. Nature, 2014, 506: 382-386 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Selection and evaluation of clinically relevant AAV variants in a xenograft liver model&author=Lisowski L.&author=Dane A.P.&author=Chu K.&author=Zhang Y.&author=Cunningham S.C.&author=Wilson E.M.&author=Nygaard S.&author=Grompe M.&author=Alexander I.E.&author=Kay M.A.&publication_year=2014&journal=Nature&volume=506&pages=382-386

[44] Long C., McAnally J.R., Shelton J.M., Mireault A.A., Bassel-Duby R., Olson E.N.. Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA. Science, 2014, 345: 1184-1188 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA&author=Long C.&author=McAnally J.R.&author=Shelton J.M.&author=Mireault A.A.&author=Bassel-Duby R.&author=Olson E.N.&publication_year=2014&journal=Science&volume=345&pages=1184-1188

[45] Lu Q.L., Yokota T., Takeda S., Garcia L., Muntoni F., Partridge T.. The status of exon skipping as a therapeutic approach to Duchenne muscular dystrophy. Mol Ther, 2011, 19: 9-15 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=The status of exon skipping as a therapeutic approach to Duchenne muscular dystrophy&author=Lu Q.L.&author=Yokota T.&author=Takeda S.&author=Garcia L.&author=Muntoni F.&author=Partridge T.&publication_year=2011&journal=Mol Ther&volume=19&pages=9-15

[46] Maddalo D., Manchado E., Concepcion C.P., Bonetti C., Vidigal J.A., Han Y.C., Ogrodowski P., Crippa A., Rekhtman N., de Stanchina E., Lowe S.W., Ventura A.. In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature, 2014, 516: 423-427 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system&author=Maddalo D.&author=Manchado E.&author=Concepcion C.P.&author=Bonetti C.&author=Vidigal J.A.&author=Han Y.C.&author=Ogrodowski P.&author=Crippa A.&author=Rekhtman N.&author=de Stanchina E.&author=Lowe S.W.&author=Ventura A.&publication_year=2014&journal=Nature&volume=516&pages=423-427

[47] Mali P., Esvelt K.M., Church G.M.. Cas9 as a versatile tool for engineering biology. Nat Meth, 2013a, 10: 957-963 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Cas9 as a versatile tool for engineering biology&author=Mali P.&author=Esvelt K.M.&author=Church G.M.&publication_year=2013a&journal=Nat Meth&volume=10&pages=957-963

[48] Mali P., Yang L., Esvelt K.M., Aach J., Guell M., DiCarlo J.E., Norville J.E., Church G.M.. RNA-guided human genome engineering via Cas9. Science, 2013b, 339: 823-826 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=RNA-guided human genome engineering via Cas9&author=Mali P.&author=Yang L.&author=Esvelt K.M.&author=Aach J.&author=Guell M.&author=DiCarlo J.E.&author=Norville J.E.&author=Church G.M.&publication_year=2013b&journal=Science&volume=339&pages=823-826

[49] Manno C.S., Pierce G.F., Arruda V.R., Glader B., Ragni M., Rasko J.J., Rasko J., Ozelo M.C., Hoots K., Blatt P., Konkle B., Dake M., Kaye R., Razavi M., Zajko A., Zehnder J., Rustagi P.K., Nakai H., Chew A., Leonard D., Wright J.F., Lessard R.R., Sommer J.M., Tigges M., Sabatino D., Luk A., Jiang H., Mingozzi F., Couto L., Ertl H.C., High K.A., Kay M.A.. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med, 2006, 12: 342-347 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response&author=Manno C.S.&author=Pierce G.F.&author=Arruda V.R.&author=Glader B.&author=Ragni M.&author=Rasko J.J.&author=Rasko J.&author=Ozelo M.C.&author=Hoots K.&author=Blatt P.&author=Konkle B.&author=Dake M.&author=Kaye R.&author=Razavi M.&author=Zajko A.&author=Zehnder J.&author=Rustagi P.K.&author=Nakai H.&author=Chew A.&author=Leonard D.&author=Wright J.F.&author=Lessard R.R.&author=Sommer J.M.&author=Tigges M.&author=Sabatino D.&author=Luk A.&author=Jiang H.&author=Mingozzi F.&author=Couto L.&author=Ertl H.C.&author=High K.A.&author=Kay M.A.&publication_year=2006&journal=Nat Med&volume=12&pages=342-347

[50] Mingozzi F., High K.A.. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet, 2011, 12: 341-355 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges&author=Mingozzi F.&author=High K.A.&publication_year=2011&journal=Nat Rev Genet&volume=12&pages=341-355

[51] Morrissey D.V., Lockridge J.A., Shaw L., Blanchard K., Jensen K., Breen W., Hartsough K., Machemer L., Radka S., Jadhav V., Vaish N., Zinnen S., Vargeese C., Bowman K., Shaffer C.S., Jeffs L.B., Judge A., MacLachlan I., Polisky B.. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol, 2005, 23: 1002-1007 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs&author=Morrissey D.V.&author=Lockridge J.A.&author=Shaw L.&author=Blanchard K.&author=Jensen K.&author=Breen W.&author=Hartsough K.&author=Machemer L.&author=Radka S.&author=Jadhav V.&author=Vaish N.&author=Zinnen S.&author=Vargeese C.&author=Bowman K.&author=Shaffer C.S.&author=Jeffs L.B.&author=Judge A.&author=MacLachlan I.&author=Polisky B.&publication_year=2005&journal=Nat Biotechnol&volume=23&pages=1002-1007

[52] Mukherjee S., Thrasher A.J.. iPSCs: unstable origins?. Mol Ther, 2011, 19: 1188-1190 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=iPSCs: unstable origins?&author=Mukherjee S.&author=Thrasher A.J.&publication_year=2011&journal=Mol Ther&volume=19&pages=1188-1190

[53] Nathwani A.C., Gray J.T., Ng C.Y.C., Zhou J., Spence Y., Waddington S.N., Tuddenham E.G.D., Kemball-Cook G., McIntosh J., Boon-Spijker M., Mertens K., Davidoff A.M.. Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood, 2006, 107: 2653-2661 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver&author=Nathwani A.C.&author=Gray J.T.&author=Ng C.Y.C.&author=Zhou J.&author=Spence Y.&author=Waddington S.N.&author=Tuddenham E.G.D.&author=Kemball-Cook G.&author=McIntosh J.&author=Boon-Spijker M.&author=Mertens K.&author=Davidoff A.M.&publication_year=2006&journal=Blood&volume=107&pages=2653-2661

[54] Nathwani A.C., Tuddenham E.G.D., Rangarajan S., Rosales C., McIntosh J., Linch D.C., Chowdary P., Riddell A., Pie A.J., Harrington C., O'Beirne J., Smith K., Pasi J., Glader B., Rustagi P., Ng C.Y.C., Kay M.A., Zhou J., Spence Y., Morton C.L., Allay J., Coleman J., Sleep S., Cunningham J.M., Srivastava D., Basner-Tschakarjan E., Mingozzi F., High K.A., Gray J.T., Reiss U.M., Nienhuis A.W., Davidoff A.M.. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med, 2011, 365: 2357-2365 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Adenovirus-associated virus vector-mediated gene transfer in hemophilia B&author=Nathwani A.C.&author=Tuddenham E.G.D.&author=Rangarajan S.&author=Rosales C.&author=McIntosh J.&author=Linch D.C.&author=Chowdary P.&author=Riddell A.&author=Pie A.J.&author=Harrington C.&author=O'Beirne J.&author=Smith K.&author=Pasi J.&author=Glader B.&author=Rustagi P.&author=Ng C.Y.C.&author=Kay M.A.&author=Zhou J.&author=Spence Y.&author=Morton C.L.&author=Allay J.&author=Coleman J.&author=Sleep S.&author=Cunningham J.M.&author=Srivastava D.&author=Basner-Tschakarjan E.&author=Mingozzi F.&author=High K.A.&author=Gray J.T.&author=Reiss U.M.&author=Nienhuis A.W.&author=Davidoff A.M.&publication_year=2011&journal=N Engl J Med&volume=365&pages=2357-2365

[55] Nikiforova M.N., Stringer J.R., Blough R., Medvedovic M., Fagin J.A., Nikiforov Y.E.. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science, 2000, 290: 138-141 CrossRef ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells&author=Nikiforova M.N.&author=Stringer J.R.&author=Blough R.&author=Medvedovic M.&author=Fagin J.A.&author=Nikiforov Y.E.&publication_year=2000&journal=Science&volume=290&pages=138-141

[56] Okada T., Takeda S.. Current challenges and future directions in recombinant AAV-mediated gene therapy of Duchenne muscular dystrophy. Pharmaceuticals, 2013, 6: 813-836 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Current challenges and future directions in recombinant AAV-mediated gene therapy of Duchenne muscular dystrophy&author=Okada T.&author=Takeda S.&publication_year=2013&journal=Pharmaceuticals&volume=6&pages=813-836

[57] Olivares E.C., Hollis R.P., Chalberg T.W., Meuse L., Kay M.A., Calos M.P.. Site-specific genomic integration produces therapeutic factor IX levels in mice. Nat Biotech, 2002, 20: 1124-1128 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Site-specific genomic integration produces therapeutic factor IX levels in mice&author=Olivares E.C.&author=Hollis R.P.&author=Chalberg T.W.&author=Meuse L.&author=Kay M.A.&author=Calos M.P.&publication_year=2002&journal=Nat Biotech&volume=20&pages=1124-1128

[58] Ott J., Kamatani Y., Lathrop M.. Family-based designs for genome-wide association studies. Nat Rev Genet, 2011, 12: 465-474 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Family-based designs for genome-wide association studies&author=Ott J.&author=Kamatani Y.&author=Lathrop M.&publication_year=2011&journal=Nat Rev Genet&volume=12&pages=465-474

[59] Ousterout D.G., Kabadi A.M., Thakore P.I., Majoros W.H., Reddy T.E., Gersbach C.A.. Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy. Nat Commun, 2015, 6: 6244 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy&author=Ousterout D.G.&author=Kabadi A.M.&author=Thakore P.I.&author=Majoros W.H.&author=Reddy T.E.&author=Gersbach C.A.&publication_year=2015&journal=Nat Commun&volume=6&pages=6244

[60] Park C.Y., Kim D.H., Son J.S., Sung J.J., Lee J., Bae S., Kim J.H., Kim D.W., Kim J.S.. Functional correction of large factor VIII gene chromosomal inversions in hemophilia A patient-derived iPSCs using CRISPR-Cas9. Cell Stem Cell, 2015, 17: 213-220 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Functional correction of large factor VIII gene chromosomal inversions in hemophilia A patient-derived iPSCs using CRISPR-Cas9&author=Park C.Y.&author=Kim D.H.&author=Son J.S.&author=Sung J.J.&author=Lee J.&author=Bae S.&author=Kim J.H.&author=Kim D.W.&author=Kim J.S.&publication_year=2015&journal=Cell Stem Cell&volume=17&pages=213-220

[61] Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K., Daley G.Q.. Disease-specific induced pluripotent stem cells. Cell, 2008, 134: 877-886 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Disease-specific induced pluripotent stem cells&author=Park I.H.&author=Arora N.&author=Huo H.&author=Maherali N.&author=Ahfeldt T.&author=Shimamura A.&author=Lensch M.W.&author=Cowan C.&author=Hochedlinger K.&author=Daley G.Q.&publication_year=2008&journal=Cell&volume=134&pages=877-886

[62] Paulk N.K., Wursthorn K., Wang Z., Finegold M.J., Kay M.A., Grompe M.. Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo. Hepatology, 2010, 51: 1200-1208 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo&author=Paulk N.K.&author=Wursthorn K.&author=Wang Z.&author=Finegold M.J.&author=Kay M.A.&author=Grompe M.&publication_year=2010&journal=Hepatology&volume=51&pages=1200-1208

[63] Pichavant C., Aartsma-Rus A., Clemens P.R., Davies K.E., Dickson G., Takeda S., Wilton S.D., Wolff J.A., Wooddell C.I., Xiao X., Tremblay J.P.. Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther, 2011, 19: 830-840 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Current status of pharmaceutical and genetic therapeutic approaches to treat DMD&author=Pichavant C.&author=Aartsma-Rus A.&author=Clemens P.R.&author=Davies K.E.&author=Dickson G.&author=Takeda S.&author=Wilton S.D.&author=Wolff J.A.&author=Wooddell C.I.&author=Xiao X.&author=Tremblay J.P.&publication_year=2011&journal=Mol Ther&volume=19&pages=830-840

[64] Piras B.A., Drury J.E., Morton C.L., Spence Y., Lockey T.D., Nathwani A.C., Davidoff A.M., Meagher M.M.. Distribution of AAV8 particles in cell lysates and culture media changes with time and is dependent on the recombinant vector. Mol Ther Methods Clin Dev, 2016, 3: 16015 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Distribution of AAV8 particles in cell lysates and culture media changes with time and is dependent on the recombinant vector&author=Piras B.A.&author=Drury J.E.&author=Morton C.L.&author=Spence Y.&author=Lockey T.D.&author=Nathwani A.C.&author=Davidoff A.M.&author=Meagher M.M.&publication_year=2016&journal=Mol Ther Methods Clin Dev&volume=3&pages=16015

[65] Pirazzoli V., Nebhan C., Song X., Wurtz A., Walther Z., Cai G., Zhao Z., Jia P., de Stanchina E., Shapiro E.M., Gale M., Yin R., Horn L., Carbone D.P., Stephens P.J., Miller V., Gettinger S., Pao W., Politi K.. Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1. Cell Rep, 2014, 7: 999-1008 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1&author=Pirazzoli V.&author=Nebhan C.&author=Song X.&author=Wurtz A.&author=Walther Z.&author=Cai G.&author=Zhao Z.&author=Jia P.&author=de Stanchina E.&author=Shapiro E.M.&author=Gale M.&author=Yin R.&author=Horn L.&author=Carbone D.P.&author=Stephens P.J.&author=Miller V.&author=Gettinger S.&author=Pao W.&author=Politi K.&publication_year=2014&journal=Cell Rep&volume=7&pages=999-1008

[66] Platt R.J., Chen S., Zhou Y., Yim M.J., Swiech L., Kempton H.R., Dahlman J.E., Parnas O., Eisenhaure T.M., Jovanovic M., Graham D.B., Jhunjhunwala S., Heidenreich M., Xavier R.J., Langer R., Anderson D.G., Hacohen N., Regev A., Feng G., Sharp P.A., Zhang F.. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell, 2014, 159: 440-455 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=CRISPR-Cas9 knockin mice for genome editing and cancer modeling&author=Platt R.J.&author=Chen S.&author=Zhou Y.&author=Yim M.J.&author=Swiech L.&author=Kempton H.R.&author=Dahlman J.E.&author=Parnas O.&author=Eisenhaure T.M.&author=Jovanovic M.&author=Graham D.B.&author=Jhunjhunwala S.&author=Heidenreich M.&author=Xavier R.J.&author=Langer R.&author=Anderson D.G.&author=Hacohen N.&author=Regev A.&author=Feng G.&author=Sharp P.A.&author=Zhang F.&publication_year=2014&journal=Cell&volume=159&pages=440-455

[67] Porteus M.H., Dann C.T.. Genome editing of the germline: broadening the discussion. Mol Ther, 2015, 23: 980-982 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Genome editing of the germline: broadening the discussion&author=Porteus M.H.&author=Dann C.T.&publication_year=2015&journal=Mol Ther&volume=23&pages=980-982

[68] Ran F.A., Cong L., Yan W.X., Scott D.A., Gootenberg J.S., Kriz A.J., Zetsche B., Shalem O., Wu X., Makarova K.S., Koonin E.V., Sharp P.A., Zhang F.. In vivo genome editing using Staphylococcus aureus Cas9. Nature, 2015, 520: 186-191 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=In vivo genome editing using Staphylococcus aureus Cas9&author=Ran F.A.&author=Cong L.&author=Yan W.X.&author=Scott D.A.&author=Gootenberg J.S.&author=Kriz A.J.&author=Zetsche B.&author=Shalem O.&author=Wu X.&author=Makarova K.S.&author=Koonin E.V.&author=Sharp P.A.&author=Zhang F.&publication_year=2015&journal=Nature&volume=520&pages=186-191

[69] Raya A., Rodríguez-Pizà I., Guenechea G., Vassena R., Navarro S., Barrero M.J., Consiglio A., Castellà M., Río P., Sleep E., González F., Tiscornia G., Garreta E., Aasen T., Veiga A., Verma I.M., Surrallés J., Bueren J., Izpisúa Belmonte J.C.. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature, 2009, 460: 53-59 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells&author=Raya A.&author=Rodríguez-Pizà I.&author=Guenechea G.&author=Vassena R.&author=Navarro S.&author=Barrero M.J.&author=Consiglio A.&author=Castellà M.&author=Río P.&author=Sleep E.&author=González F.&author=Tiscornia G.&author=Garreta E.&author=Aasen T.&author=Veiga A.&author=Verma I.M.&author=Surrallés J.&author=Bueren J.&author=Izpisúa Belmonte J.C.&publication_year=2009&journal=Nature&volume=460&pages=53-59

[70] Robinton D.A., Daley G.Q.. The promise of induced pluripotent stem cells in research and therapy. Nature, 2012, 481: 295-305 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=The promise of induced pluripotent stem cells in research and therapy&author=Robinton D.A.&author=Daley G.Q.&publication_year=2012&journal=Nature&volume=481&pages=295-305

[71] Savi? N., Schwank G.. Advances in therapeutic CRISPR/Cas9 genome editing. Transl Res, 2016, 168: 15-21 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Advances in therapeutic CRISPR/Cas9 genome editing&author=Savi? N.&author=Schwank G.&publication_year=2016&journal=Transl Res&volume=168&pages=15-21

[72] Schwank G., Koo B.K., Sasselli V., Dekkers J.F., Heo I., Demircan T., Sasaki N., Boymans S., Cuppen E., van der Ent C.K., Nieuwenhuis E.E.S., Beekman J.M., Clevers H.. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell, 2013, 13: 653-658 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients&author=Schwank G.&author=Koo B.K.&author=Sasselli V.&author=Dekkers J.F.&author=Heo I.&author=Demircan T.&author=Sasaki N.&author=Boymans S.&author=Cuppen E.&author=van der Ent C.K.&author=Nieuwenhuis E.E.S.&author=Beekman J.M.&author=Clevers H.&publication_year=2013&journal=Cell Stem Cell&volume=13&pages=653-658

[73] Sebestyén M.G., Budker V.G., Budker T., Subbotin V.M., Zhang G., Monahan S.D., Lewis D.L., Wong S.C., Hagstrom J.E., Wolff J.A.. Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various molecules. J Gene Med, 2006, 8: 852-873 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various molecules&author=Sebestyén M.G.&author=Budker V.G.&author=Budker T.&author=Subbotin V.M.&author=Zhang G.&author=Monahan S.D.&author=Lewis D.L.&author=Wong S.C.&author=Hagstrom J.E.&author=Wolff J.A.&publication_year=2006&journal=J Gene Med&volume=8&pages=852-873

[74] Sharpless N.E., Depinho R.A.. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov, 2006, 5: 741-754 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=The mighty mouse: genetically engineered mouse models in cancer drug development&author=Sharpless N.E.&author=Depinho R.A.&publication_year=2006&journal=Nat Rev Drug Discov&volume=5&pages=741-754

[75] Shinmyo Y., Tanaka S., Tsunoda S., Hosomichi K., Tajima A., Kawasaki H.. CRISPR/Cas9-mediated gene knockout in the mouse brain using in utero electroporation. Sci Rep, 2016, 6: 20611 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=CRISPR/Cas9-mediated gene knockout in the mouse brain using in utero electroporation&author=Shinmyo Y.&author=Tanaka S.&author=Tsunoda S.&author=Hosomichi K.&author=Tajima A.&author=Kawasaki H.&publication_year=2016&journal=Sci Rep&volume=6&pages=20611

[76] Smith K.R.. Gene therapy: the potential applicability of gene transfer technology to the human germline. Int J Med Sci, 2004, 1: 76-91 CrossRef Google Scholar http://scholar.google.com/scholar_lookup?title=Gene therapy: the potential applicability of gene transfer technology to the human germline&author=Smith K.R.&publication_year=2004&journal=Int J Med Sci&volume=1&pages=76-91

[77] Song B., Fan Y., He W., Zhu D., Niu X., Wang D., Ou Z., Luo M., Sun X.. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system. Stem Cells Dev, 2015, 24: 1053-1065 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system&author=Song B.&author=Fan Y.&author=He W.&author=Zhu D.&author=Niu X.&author=Wang D.&author=Ou Z.&author=Luo M.&author=Sun X.&publication_year=2015&journal=Stem Cells Dev&volume=24&pages=1053-1065

[78] Suda T., Liu D.. Hydrodynamic gene delivery: its principles and applications. Mol Ther, 2007, 15: 2063-2069 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Hydrodynamic gene delivery: its principles and applications&author=Suda T.&author=Liu D.&publication_year=2007&journal=Mol Ther&volume=15&pages=2063-2069

[79] Swiech L., Heidenreich M., Banerjee A., Habib N., Li Y., Trombetta J., Sur M., Zhang F.. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol, 2015, 33: 102-106 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9&author=Swiech L.&author=Heidenreich M.&author=Banerjee A.&author=Habib N.&author=Li Y.&author=Trombetta J.&author=Sur M.&author=Zhang F.&publication_year=2015&journal=Nat Biotechnol&volume=33&pages=102-106

[80] Takahashi K., Yamanaka S.. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126: 663-676 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors&author=Takahashi K.&author=Yamanaka S.&publication_year=2006&journal=Cell&volume=126&pages=663-676

[81] Trounson A., DeWitt N.D.. Pluripotent stem cells progressing to the clinic. Nat Rev Mol Cell Biol, 2016, 17: 194-200 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Pluripotent stem cells progressing to the clinic&author=Trounson A.&author=DeWitt N.D.&publication_year=2016&journal=Nat Rev Mol Cell Biol&volume=17&pages=194-200

[82] Veltman J.A., Brunner H.G.. De novo mutations in human genetic disease. Nat Rev Genet, 2012, 13: 565-575 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=De novo mutations in human genetic disease&author=Veltman J.A.&author=Brunner H.G.&publication_year=2012&journal=Nat Rev Genet&volume=13&pages=565-575

[83] Wang H., Yang H., Shivalila C.S., Dawlaty M.M., Cheng A.W., Zhang F., Jaenisch R.. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell, 2013, 153: 910-918 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering&author=Wang H.&author=Yang H.&author=Shivalila C.S.&author=Dawlaty M.M.&author=Cheng A.W.&author=Zhang F.&author=Jaenisch R.&publication_year=2013&journal=Cell&volume=153&pages=910-918

[84] Weiner A., Zauberman N., Minsky A.. Recombinational DNA repair in a cellular context: a search for the homology search. Nat Rev Micro, 2009, 7: 748-755 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Recombinational DNA repair in a cellular context: a search for the homology search&author=Weiner A.&author=Zauberman N.&author=Minsky A.&publication_year=2009&journal=Nat Rev Micro&volume=7&pages=748-755

[85] Wu Y., Liang D., Wang Y., Bai M., Tang W., Bao S., Yan Z., Li D., Li J.. Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell, 2013, 13: 659-662 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Correction of a genetic disease in mouse via use of CRISPR-Cas9&author=Wu Y.&author=Liang D.&author=Wang Y.&author=Bai M.&author=Tang W.&author=Bao S.&author=Yan Z.&author=Li D.&author=Li J.&publication_year=2013&journal=Cell Stem Cell&volume=13&pages=659-662

[86] Xie F., Ye L., Chang J.C., Beyer A.I., Wang J., Muench M.O., Kan Y.W.. Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac. Genome Res, 2014, 24: 1526-1533 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac&author=Xie F.&author=Ye L.&author=Chang J.C.&author=Beyer A.I.&author=Wang J.&author=Muench M.O.&author=Kan Y.W.&publication_year=2014&journal=Genome Res&volume=24&pages=1526-1533

[87] Xu L., Park K.H., Zhao L., Xu J., El Refaey M., Gao Y., Zhu H., Ma J., Han R.. CRISPR-mediated genome editing restores dystrophin expression and function in mdx mice. Mol Ther, 2016, 24: 564-569 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=CRISPR-mediated genome editing restores dystrophin expression and function in mdx mice&author=Xu L.&author=Park K.H.&author=Zhao L.&author=Xu J.&author=El Refaey M.&author=Gao Y.&author=Zhu H.&author=Ma J.&author=Han R.&publication_year=2016&journal=Mol Ther&volume=24&pages=564-569

[88] Yang H., Wang H., Shivalila C.S., Cheng A.W., Shi L., Jaenisch R.. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell, 2013, 154: 1370-1379 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering&author=Yang H.&author=Wang H.&author=Shivalila C.S.&author=Cheng A.W.&author=Shi L.&author=Jaenisch R.&publication_year=2013&journal=Cell&volume=154&pages=1370-1379

[89] Yang Y., Wang L., Bell P., McMenamin D., He Z., White J., Yu H., Xu C., Morizono H., Musunuru K., Batshaw M.L., Wilson J.M.. A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice. Nat Biotechnol, 2016a, 34: 334-338 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice&author=Yang Y.&author=Wang L.&author=Bell P.&author=McMenamin D.&author=He Z.&author=White J.&author=Yu H.&author=Xu C.&author=Morizono H.&author=Musunuru K.&author=Batshaw M.L.&author=Wilson J.M.&publication_year=2016a&journal=Nat Biotechnol&volume=34&pages=334-338

[90] Yang Y., Zhang X., Yi L., Hou Z., Chen J., Kou X., Zhao Y., Wang H., Sun X.F., Jiang C., Wang Y., Gao S.. Na?ve induced pluripotent stem cells generated from β-thalassemia fibroblasts allow efficient gene correction with CRISPR/Cas9. Stem Cell Transl Med, 2016b, 5: 8-19 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Na?ve induced pluripotent stem cells generated from β-thalassemia fibroblasts allow efficient gene correction with CRISPR/Cas9&author=Yang Y.&author=Zhang X.&author=Yi L.&author=Hou Z.&author=Chen J.&author=Kou X.&author=Zhao Y.&author=Wang H.&author=Sun X.F.&author=Jiang C.&author=Wang Y.&author=Gao S.&publication_year=2016b&journal=Stem Cell Transl Med&volume=5&pages=8-19

[91] Yin H., Xue W., Chen S., Bogorad R.L., Benedetti E., Grompe M., Koteliansky V., Sharp P.A., Jacks T., Anderson D.G.. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat Biotechnol, 2014, 32: 551-553 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype&author=Yin H.&author=Xue W.&author=Chen S.&author=Bogorad R.L.&author=Benedetti E.&author=Grompe M.&author=Koteliansky V.&author=Sharp P.A.&author=Jacks T.&author=Anderson D.G.&publication_year=2014&journal=Nat Biotechnol&volume=32&pages=551-553

[92] Yoshimi K., Kaneko T., Voigt B., Mashimo T.. Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-Cas platform. Nat Commun, 2014, 5: 4240 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-Cas platform&author=Yoshimi K.&author=Kaneko T.&author=Voigt B.&author=Mashimo T.&publication_year=2014&journal=Nat Commun&volume=5&pages=4240

[93] Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A.. Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007, 318: 1917-1920 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Induced pluripotent stem cell lines derived from human somatic cells&author=Yu J.&author=Vodyanik M.A.&author=Smuga-Otto K.&author=Antosiewicz-Bourget J.&author=Frane J.L.&author=Tian S.&author=Nie J.&author=Jonsdottir G.A.&author=Ruotti V.&author=Stewart R.&author=Slukvin I.I.&author=Thomson J.A.&publication_year=2007&journal=Science&volume=318&pages=1917-1920

[94] Yu Z., Ren M., Wang Z., Zhang B., Rong Y.S., Jiao R., Gao G.. Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila. Genets, 2013, 195: 289-291 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila&author=Yu Z.&author=Ren M.&author=Wang Z.&author=Zhang B.&author=Rong Y.S.&author=Jiao R.&author=Gao G.&publication_year=2013&journal=Genets&volume=195&pages=289-291

[95] Zhang D., Li J.F.. DNA-guided genome editing tool. Sci China Life Sci, 2016, 59: 740-741 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=DNA-guided genome editing tool&author=Zhang D.&author=Li J.F.&publication_year=2016&journal=Sci China Life Sci&volume=59&pages=740-741

[96] Zhang D., Li Z., Yan B., Li J.F.. A novel RNA-guided RNA-targeting CRISPR tool. Sci China Life Sci, 2016, 59: 854-856 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=A novel RNA-guided RNA-targeting CRISPR tool&author=Zhang D.&author=Li Z.&author=Yan B.&author=Li J.F.&publication_year=2016&journal=Sci China Life Sci&volume=59&pages=854-856

[97] Zhang X., Wang S.. From the first human gene-editing to the birth of three-parent baby. Sci China Life Sci, 2016, 59: 1341-1342 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=From the first human gene-editing to the birth of three-parent baby&author=Zhang X.&author=Wang S.&publication_year=2016&journal=Sci China Life Sci&volume=59&pages=1341-1342

[98] Zincarelli C., Soltys S., Rengo G., Rabinowitz J.E.. Analysis of AAV serotypes 1–9 mediated gene expression and tropism in mice after systemic injection. Mol Ther, 2008, 16: 1073-1080 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Analysis of AAV serotypes 1–9 mediated gene expression and tropism in mice after systemic injection&author=Zincarelli C.&author=Soltys S.&author=Rengo G.&author=Rabinowitz J.E.&publication_year=2008&journal=Mol Ther&volume=16&pages=1073-1080